Menu Menu

TLIS    Talis Biomedical Corp    1584751    
Income Statement
Net Income -8,849,000

Balance Sheet
Current Assets 63,601,000
Assets 72,699,000
Current Liabilities 8,196,000
Liabilities 24,073,000
Equity 48,626,000
Shares Out 1,823,000

Cash Flow Statement
Operating Cash Flow -17,757,000
Investing Cash Flow 114,000

Market Analysis
Market Cap 3,370,981
Price 1.90
BVPS 26.67
PB 0.07
EPS -28.02
PS 0.36
FCF -17,643,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
0.57
Apr May Jun
5/08 -7.15
Jul Aug Sep
8/19 -4.86
Oct Nov Dec
11/12

Find a discrepancy? The most accurate way to find company fundamental data is to view TLIS documents filed with the SEC.


TLIS Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: